Business

Announcement on Voluntary Disclosure of Obtaining Notice of Approval for Drug Clinical Trial of Holding Subsidiary's Recombinant Shingles Vaccine SCTV04C

Announcement on Voluntary Disclosure of Obtaining Notice of Approval for Drug Clinical Trial of Holding Subsidiary's Recombinant Shingles Vaccine SCTV04C

articleSinocelltech Group Limited Class ASeptember 5, 20245/news/announcement-on-voluntary-disclosure-of-obtaining-notice-of-approval-for-drug-clinical-trial-of-holding-subsidiarys-recombinant-shingles-vaccine-sctv04c
Announcement on Voluntary Disclosure of Obtaining Notice of Approval for Drug Clinical Trial of Holding Subsidiary's Recombinant Shingles Vaccine SCTV04C

About this update from Sinocelltech Group Limited Class A

Announcement on Voluntary Disclosure of Obtaining Notice of Approval for Drug Clinical Trial of Holding Subsidiary's Recombinant Shingles Vaccine SCTV04CThe abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Sinocelltech Group Limited Class A